Sort
21,281 grants matching “influenza”
Public health targeting of PrEP at HIV positives' bridging networks
$223,267John Schneider · University Of Chicago · R21 · FY2015 · AI
Engineered enzyme sensors based on allosteric regulation
$223,262Wlodek Mandecki · Pharmaseq, Inc. · R43 · FY2019 · GM
Systems biological assessment of innate and adaptive immunity to vaccination
$223,238Bali Pulendran · Stanford University · U19 · FY2023 · AI
Development of novel broad-spectrum influenza A inhibitors
$223,202Ken J McCormack · Arisan Therapeutics, Inc. · R43 · FY2011 · AI
A Porcine Model for Torque Teno Virus Infections
$223,176Sheela Ramamoorthy · North Dakota State University · R21 · FY2018 · AI
Real-time estimation of influenza vaccine effectiveness through social media mining
$223,166Graciela Gonzalez Hernandez · Cedars-Sinai Medical Center · R21 · FY2024 · LM
Control of interferon-activated necrosis by a virus-triggered FADD checkpoint
$223,125Siddharth Balachandran · Research Inst Of Fox Chase Can Ctr · R21 · FY2014 · AI
Emerging Infectious Diseases Training Program
$223,050Kathleen A. McDonough · Wadsworth Center · T32 · FY2013 · AI
Tulane Xavier Minority Training in International Health
$223,030Richard A Oberhelman · Tulane University Of Louisiana · T37 · FY2016 · MD
Supplement request for Ebola diagnostic assay development
$223,021David Alland · Rbhs-New Jersey Medical School · R01 · FY2015 · AI
Determining the Impact of Semisynthetic Saponin Immunologic Adjuvant Titerquil-1055 on Influenza Vaccine Immunogenicity and Stability
$223,002Philip Livingston · Adjuvance Technologies, Inc. · N43 · FY2017 · AI
Aptamer-enabled multiplex electrochemical sensor for robust and efficient assessment of flu vaccine potency
$222,999Brian Scott Ferguson · Aptitude Medical Systems, Inc. · R43 · FY2019 · AI
EMORY VACCINE CENTER
$222,990Rafi Ahmed · Emory University · P51 · FY2011 · RR
Modeling influenza virus replication in primary human lung cells
$222,889Frederick T Koster · Lovelace Biomedical & Environmental Research Institute · R21 · FY2008 · AI
Broadly Neutralizing Antibodies Against Human Pathogenic Old World Arenaviruses
$222,800Luis Martinez-Sobrido · University Of Rochester · R21 · FY2016 · AI
Immune response to inhalation of live attenuated vaccine in an outbred tularemia model (Resubmission)
$222,796Douglas Scott Reed · University Of Pittsburgh At Pittsburgh · R21 · FY2022 · AI
Utilizing alternative dietary interventions to alter gut microbiome and improve T cell responses to viral infection in obesity
$222,787Nancie Maciver · Univ Of North Carolina Chapel Hill · R21 · FY2025 · AI
Role of VpreB in immunoglobulin antigen binding site selection
$222,750Harry William Schroeder · University Of Alabama At Birmingham · R21 · FY2018 · AI
Assessing Flu-specific Humoral Immunity in Human Lung after Ex Vivo Lung Perfusion
$222,750Anoma Nellore · University Of Alabama At Birmingham · R21 · FY2021 · AI
Surveillance of wildlife and livestock for novel and emerging coronaviruses
$222,750Eric A Nelson · South Dakota State University · R21 · FY2021 · AI
GC-Tfh cell differentiation
$222,750Hui Hu · University Of Alabama At Birmingham · R21 · FY2021 · AI
Dysbiotic Infections in Chronic Obstructive Pulmonary Disease
$222,750William E Swords · University Of Alabama At Birmingham · R21 · FY2018 · AI
Determining the role of NLRP3 on the placement and protective potential of CD73+ BRMs post influenza infection
$222,750S Rameeza Allie · University Of Alabama At Birmingham · R21 · FY2020 · AI
A Novel Approach for Mycobacterium Tuberculosis Vaccine Development
$222,750Biao He · University Of Georgia · R21 · FY2014 · AI
Thiol mediated redox homeostasis in Haemophilus influenzae biofilms
$222,750William E Swords · University Of Alabama At Birmingham · R21 · FY2020 · AI